10,000
Participants
Start Date
April 30, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
February 28, 2026
Methylation Test
"Participants who aged 25-65 years with high-risk HPV infection are recruited.To start with,cervical exfoliated cells are collected, coded (according to the actual enrollment sequence), and stored in the pathology department where methylation testing is performed.In addition,patients will underwent colposcopy and biopsy.~Patients are followed up by cytology, high-risk HPV and methylation tests at 6 and 12 months after enrollment.Cervical conization and hysterectomy will be taken if necessary according to histopathological results. The clinical endpoint is reached when CIN2+ is confirmed by histopathological result."
Obstetrics and Gynecology Hospital of Fudan University, Shanghai
Peking Union Medical College Hospital
OTHER
Chengdu Women's and Children's Central Hospital
OTHER
Guangdong Women and Children Hospital
OTHER
Second Hospital of Jilin University
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
Third Affiliated Hospital of Zhengzhou University
OTHER
Obstetrics & Gynecology Hospital of Fudan University
OTHER